Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, the Company aims to rapidly translate it's treatments from bench to bedside. Taysha Gene have combined it's team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program. Together, the company leverage it's fully integrated platform with a goal of dramatically improving patients’ lives.